PRESSURE is growing for the British government and pharmaceutical companies across the globe to end the “vaccine apartheid” of restrictive patents, which deny supplies to poorer countries. One year on from the World Health Organisation’s (WHO) declaration of the coronavirus pandemic, fresh campaigns have been launched to unlock vaccines for low and middle-income countries and accelerate the end of global restrictions. Amnesty International is launching its “A Fair Shot” campaign today, urging politicians and pharmaceuticals giants, such as AstraZeneca, Pfizer, BioNTech and Moderna, to share knowledge and technology to maximise the number of doses of vaccines available worldwide. The group is calling on governments to avoid “vaccine nationalism” and work together so those most at risk of Covid-19 can access life-saving preventative treatment immediately.